ArticleInternational journal of general medicine2025
Comparative Analysis of the Effects of Propofol and Sevoflurane on Coagulation and Immune System Function in Patients Undergoing Radical Surgery for Colon Cancer.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sevoflurane Inhibits Colon Cancer Progression by Inducing Cell Autophagy and Apoptosis through the ROS/Nrf2/P62 Pathway.Oncology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To compare the effects of intravenous anesthesia with propofol and inhalation anesthesia with sevoflurane on coagulation and immune system function in patients undergoing radical surgery for colon cancer. Methods: The following were compared between the two groups: blood rheology indicators [plasma viscosity (PV), erythrocyte aggregation index (EAI), erythrocyte deformability index (EDI)], coagulation function indicators [prothrombin time (PT), activated partial thromboplastin time (APTT), D-dimer (D-D), fibrinogen (FIB)], humoral immune function indicators [immunoglobulin A (IgA), immunoglobulin M (IgM), immunoglobulin G (IgG)], cellular immune function indicators [CD4+, CD8+, natural killer cells (NK)], postoperative recovery, and postoperative complications. Results: ① Blood Rheology Indicators: At 60 minutes after anesthesia induction, PV, EAI, and EDI levels in both groups decreased compared to pre-anesthesia levels (P < 0.05), with no significant differences between the two groups at the same time point (P > 0.05). ② Coagulation Function Indicators: At 1 day postoperatively, D-D and FIB levels increased compared to 1 day preoperatively, with Group A showing less pronounced changes than Group B (P < 0.05). ③ Humoral Immune Function Indicators: In Group A, humoral immune indicators showed no significant changes at 1 day postoperatively compared to 1 day preoperatively (P > 0.05). In Group B, IgM and IgG levels decreased at 1 day postoperatively compared to 1 day preoperatively and were lower than those in Group A at the same time point (P < 0.05). ④ Cellular Immune Function Indicators: At 1 day postoperatively, CD4+, CD8+, and NK cell levels decreased in both groups compared to 1 day preoperatively. Conclusion: Propofol and sevoflurane have similar effects on perioperative blood rheology in colon cancer patients. However, propofol has a lesser impact on coagulation and immune function compared to sevoflurane, making it more effective in promoting postoperative recovery and reducing the risk of related postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.